Intratumoral Cancer Therapy Market
Aug 05, 2026
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Summary Intra-tumoral cancer therapies involve the direct administration of antitumor agents into tumors, promoting localized tumor destruction, stimulating the release of tumor-associated antigens, and activating an immune response within the tumor microenvironment that may also generate systemic antitumor eff...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
